Showing results (1281-1290 of 30,375) with videos related to
Sort By:
Pageof 3,038
Frontiers in Pharmacology|May 9, 2025
Corrigendum: Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targetingMin Qiang, Zhe Chen, Hongyang Liu, et al.Frontiers in Pharmacology|May 9, 2025
Hydroxychloroquine increases the exposure of methotrexate in plasma and red blood cells: a pharmacokinetic interaction study in rats in vivoGuijie Zhang, Rui Wang, Geping Chen, et al.Frontiers in Pharmacology|May 9, 2025
Multi-target neuroprotection by dl-PHPB in APP/PS1 mice: a proteomic analysisYingni Sun, Guoliang Bai, Kangmin Yang, et al.Frontiers in Pharmacology|May 9, 2025
Exploring the diagnostic potential of IL1R1 in depression and its association with lipid metabolismYao Gao, Xiao-Na Song, Nan Zhang, et al.Frontiers in Pharmacology|May 12, 2025
Edaravone dexborneol protected neurological function by targeting NRF2/ARE and NF-κB/AIM2 pathways in cerebral ischemia/reperfusion injuryHui Zhang, Can Zhu, Xingyu Zhou, et al.Frontiers in Pharmacology|May 7, 2025
GluN2B influences the progression of status epilepticus by modulating calcium ion homeostasis through its interaction with CaMKIIαLin Zhang, Youshi Meng, Chaoning Liu, et al.Frontiers in Pharmacology|May 7, 2025
Multi - dimensional mechanism analysis of Choerospondias axillaris (Roxb.) Burtt et Hill in treating kidney stones: network pharmacology, molecular docking and in vitro experimental verificationMeiqi Qiu, Senhua Li, Yu Zhang, et al.Frontiers in Pharmacology|May 7, 2025
Targeting fibroblast growth factor (FGF)-21: a promising strategy for metabolic dysfunction-associated steatotic liver disease treatmentXinyue Cui, Quanhao Sun, Haiqiang WangFrontiers in Pharmacology|May 8, 2025
Pharmacokinetics and bioequivalence assessment of two prucalopride formulations in healthy Chinese women: a randomized, open-label, two-period, two-sequence, self-crossover studyXiangxin Huang, Ying Wang, Bei Li, et al.Frontiers in Pharmacology|May 7, 2025
Curcumin as a potential therapeutic agent for Parkinson's disease: a systematic reviewYu-Hsien ChangPageof 3,038